Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.10

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.10, versus ($0.10) reported last year. Revenue for the quarter came in at $9.3 million, versus $8.05 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Equinox Gold Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders to Approve Business Combination with Orla Mining
• Cerebras Q1 EPS miss sends shares down 9% after-hours